Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease

Human Molecular Genetics
Maria BjörkqvistHindrik Mulder

Abstract

Huntington's disease (HD) is characterized by a triad of motor, psychiatric and cognitive symptoms. Although many of these symptoms are likely to be related to central nervous system pathology, others may be due to changes in peripheral tissues. The R6/2 mouse, a transgenic model of HD expressing exon 1 of the human HD gene, develops progressive alterations in the hypothalamic-pituitary-adrenal axis, reminiscent of a Cushing-like syndrome. We observed muscular atrophy, reduced bone mineral density, abdominal fat accumulation and insulin resistance in the mice. All these changes could be consequences of increased glucocorticoid levels. Indeed, hypertrophy of the adrenal cortex and a progressive increase in serum and urine corticosterone levels were found in R6/2 mice. In addition, the intermediate pituitary lobe was markedly enlarged and circulating adreno-corticotrophic hormone (ACTH) increased. Under normal conditions dopamine represses the ACTH expression. In the R6/2 mice, however, the expression of pituitary dopamine D2 receptors was reduced by half, possibly explaining the increase in ACTH. Urinary samples from 82 HD patients and 68 control subjects were analysed for cortisol: in accord with the observations in the R6/2 mi...Continue Reading

References

Jan 1, 1979·Neurology·I Shoulson, S Fahn
Jan 1, 1979·Monographs on Endocrinology·J D Baxter, G G Rousseau
Nov 1, 1991·Biological Psychiatry·I J HeuserM M Mouradian
Jul 1, 1990·Journal of Neuropathology and Experimental Neurology·H P KremerG T Bots
Jan 1, 1985·Clinical Genetics·L A Farrer
Apr 18, 1981·The Medical Journal of Australia·P R SanbergR F Mark
Feb 1, 1983·Clinical Endocrinology·A A KhaleeliE J Ross
Sep 1, 1995·Journal of the Neurological Sciences·F LeblhuberW Maschek
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·J H ChaA B Young
Apr 10, 1999·Human Molecular Genetics·K SathasivamG P Bates
Oct 4, 2000·Archives of General Psychiatry·R M Sapolsky
Feb 15, 2001·Archives of Neurology·S C KirkwoodT Foroud
Aug 23, 2001·Current Opinion in Clinical Nutrition and Metabolic Care·R T Jagoe, A L Goldberg
Jan 24, 2002·Trends in Pharmacological Sciences·Liliana B Menalled, Marie-Françoise Chesselet
Nov 13, 2002·Neurology·L DjousséR H Myers
Feb 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Emma HocklyGillian P Bates
May 22, 2003·American Journal of Physiology. Endocrinology and Metabolism·Robert Brommage
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Ursula F Bailer, Walter H Kaye
Dec 6, 2003·Neuroendocrinology·Jose-Luis González De AguilarJean-Philippe Loeffler
Apr 22, 2004·Nature Reviews. Neuroscience·M Flint Beal, Robert J Ferrante
May 12, 2004·BMC Neuroscience·Joana M A C GilAsa Petersén
Jun 4, 2004·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Michael Ristow
Nov 5, 2004·Human Molecular Genetics·Asa PetersénPatrik Brundin
Apr 27, 2005·Endocrinology and Metabolism Clinics of North America·Wiebke Arlt, Paul M Stewart
Jun 14, 2005·Neurobiology of Disease·Joana M A C GilAsa Petersén
Aug 30, 2005·The Journal of Comparative Neurology·Edward C StackRobert J Ferrante

❮ Previous
Next ❯

Citations

Nov 28, 2012·Journal of Neurology·Christopher A ShirbinJulie C Stout
Feb 9, 2008·Histochemistry and Cell Biology·Karl BacosNils Wierup
Sep 8, 2012·Molecular Neurobiology·Maciej FigielWlodzimierz J Krzyzosiak
Jul 16, 2008·The Journal of Experimental Medicine·Maria BjörkqvistSarah J Tabrizi
Oct 3, 2008·Brain : a Journal of Neurology·Marios PolitisPaola Piccini
Apr 21, 2011·American Journal of Physiology. Endocrinology and Metabolism·Pengxiang SheChristopher J Lynch
Feb 3, 2011·The Journal of Clinical Investigation·Ignacio Munoz-Sanjuan, Gillian P Bates
Oct 22, 2013·BMC Neurology·Carsten SaftJochen Jackowski
Nov 16, 2014·Molecular Neurodegeneration·De-Hyung LeeRalf A Linker
Aug 5, 2014·Neurobiology of Disease·Christina MoAnthony J Hannan
Jan 1, 2008·Expert Opinion on Medical Diagnostics·Edward J Wild, Sarah J Tabrizi
Oct 16, 2014·Pharmacology, Biochemistry, and Behavior·Thibault RenoirAnthony J Hannan
Aug 20, 2010·Journal of Neuropathology and Experimental Neurology·Birgit ZuckerRuth Luthi-Carter
Jul 19, 2011·Experimental Neurology·A I DuarteA C Rego
May 24, 2011·Lancet Neurology·David W WeirBlair R Leavitt
Jun 1, 2011·Neurobiology of Disease·Jorien M M van der BurgNils Wierup
Jan 13, 2016·Journal of Huntington's Disease·Andrew Christopher McCourtMaria Björkqvist
Feb 21, 2008·Experimental Neurology·Anna O G GoodmanRoger A Barker
Oct 9, 2007·Neurobiology of Disease·Jorien M M van der BurgMaria Björkqvist
Apr 17, 2007·Neurobiology of Disease·Jeremy M Van RaamsdonkBlair R Leavitt
Oct 1, 2015·Scientific Reports·Rana Soylu-KucharzÅsa Petersén
May 3, 2007·Journal of Neuroscience Research·Juan RongXiao-Jiang Li
Jul 2, 2011·British Journal of Pharmacology·Thibault RenoirAnthony J Hannan
May 16, 2014·Neurobiology of Disease·Christina MoAnthony J Hannan
Aug 24, 2010·Neurobiology of Disease·Knud JosefsenBjørn Quistorff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.